| Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to … C Fitzmaurice, C Allen, RM Barber, L Barregard, ZA Bhutta, H Brenner, ... JAMA oncology 3 (4), 524-548, 2017 | 8272 | 2017 |
| The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 SG Sepanlou, S Safiri, C Bisignano, KS Ikuta, S Merat, M Saberifiroozi, ... The Lancet gastroenterology & hepatology 5 (3), 245-266, 2020 | 1557 | 2020 |
| Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 C Abbafati, DB Machado, B Cislaghi, OM Salman, M Karanikolos, ... Deakin University, 2020 | 1387 | 2020 |
| Five insights from the global burden of disease study 2019 CJL Murray, C Abbafati, KM Abbas, M Abbasi, M Abbasi-Kangevari, ... The Lancet 396 (10258), 1135-1159, 2020 | 701 | 2020 |
| Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to … Global Burden of Disease Cancer Collaboration JAMA oncology, 2019 | 612 | 2019 |
| Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 BS Sheena, L Hiebert, H Han, H Ippolito, M Abbasi-Kangevari, ... The lancet Gastroenterology & hepatology 7 (9), 796-829, 2022 | 530 | 2022 |
| Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the … TD Frank, A Carter, D Jahagirdar, MH Biehl, D Douwes-Schultz, ... The lancet HIV 6 (12), e831-e859, 2019 | 519 | 2019 |
| Screening and treatment program to eliminate hepatitis C in Egypt I Waked, G Esmat, A Elsharkawy, M El-Serafy, W Abdel-Razek, R Ghalab, ... New England Journal of Medicine 382 (12), 1166-1174, 2020 | 266 | 2020 |
| Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019 JL Ward, PS Azzopardi, KL Francis, JS Santelli, V Skirbekk, SM Sawyer, ... The Lancet 398 (10311), 1593-1618, 2021 | 180 | 2021 |
| Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17 A Deshpande, MK Miller-Petrie, PA Lindstedt, MM Baumann, KB Johnson, ... The Lancet Global Health 8 (9), e1162-e1185, 2020 | 174 | 2020 |
| Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1 NC Galles, PY Liu, RL Updike, N Fullman, J Nguyen, S Rolfe, AN Sbarra, ... The Lancet 398 (10299), 503-521, 2021 | 166 | 2021 |
| The global distribution of lymphatic filariasis, 2000–18: a geospatial analysis EA Cromwell, CA Schmidt, KT Kwong, DM Pigott, D Mupfasoni, G Biswas, ... The Lancet Global Health 8 (9), e1186-e1194, 2020 | 166 | 2020 |
| Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease … RC Reiner, KE Wiens, A Deshpande, MM Baumann, PA Lindstedt, ... The Lancet 395 (10239), 1779-1801, 2020 | 141 | 2020 |
| Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019 D Jahagirdar, MK Walters, A Novotney, ED Brewer, TD Frank, A Carter, ... The Lancet HIV 8 (10), e633-e651, 2021 | 110 | 2021 |
| Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferon A Elsharkawy, SA Alem, R Fouad, M El Raziky, W El Akel, M Abdo, ... Journal of gastroenterology and hepatology 32 (9), 1624-1630, 2017 | 106 | 2017 |
| Mapping local patterns of childhood overweight and wasting in low-and middle-income countries between 2000 and 2017 Nature medicine 26 (5), 750-759, 2020 | 105 | 2020 |
| Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to … C Fitzmauric, C Fitzmaurice, D Abate, N Abbasi, H Abbastabar, ... JAMA oncology 5 (12), 1749-1768, 2019 | 99 | 2019 |
| Sofosbuvir‐based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt A Elsharkawy, R Fouad, W El Akel, M El Raziky, M Hassany, G Shiha, ... Alimentary pharmacology & therapeutics 45 (5), 681-687, 2017 | 85 | 2017 |
| Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: lessons from the Egyptian experience A Elsharkawy, M El-Raziky, W El-Akel, K El-Saeed, R Eletreby, ... Journal of hepatology 68 (4), 691-698, 2018 | 78 | 2018 |
| Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt G Shiha, G Esmat, M Hassany, R Soliman, M Elbasiony, R Fouad, ... Gut 68 (4), 721-728, 2019 | 66 | 2019 |
